Pdl Biopharma Inc (PDLI) CapEx to Revenue & History | Stock Alarm

Demo Sign up Log In

Pdl Biopharma Inc · CapEx to Revenue

PDLI CapEx to Revenue

Current (TTM)4.50%retrievedOct 20, 2026

PDLI CapEx/Revenue (22.42% → 4.50%)

Latest values, visible window

High-resolution chart · PNG

PDLI capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc CapEx to Revenue — Annual fiscal periods
Period ending	CapEx to Revenue
Dec 31, 2019	4.4981%
Dec 31, 2018	12.5262%
Dec 31, 2017	0.429%
Dec 31, 2016	27.8288%
Dec 31, 2015	20.7505%
Dec 31, 2014	15.2191%
Dec 31, 2013	54.4829%
Dec 31, 2012	0.0136%
Dec 31, 2011	0%
Dec 31, 2010	0%
Dec 31, 2009	0.0123%
Dec 31, 2008	1.1122%
Dec 31, 2007	36.589%
Dec 31, 2006	13.3315%
Dec 31, 2005	14.7568%
Dec 31, 2004	99.6449%
Dec 31, 2003	136.6374%
Dec 31, 2002	75.0135%
Dec 31, 2001	10.9587%
Dec 31, 2000	8.407%
Dec 31, 1999	70.1493%
Dec 31, 1998	78.8732%
Dec 31, 1997	41.4414%
Dec 31, 1996	22.4242%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.